Life-Saving Extracorporeal Membrane Oxygenation Combined with Hemoperfusion for a Pregnant Woman with COVID-19 Severe Acute Respiratory Distress Syndrome
Abstract
The pandemic of the novel coronavirus (COVID-19) affected millions of people worldwide, causing high mortality and morbidity, especially in pregnancy. The management of COVID-19, which progresses to severe acute respiratory distress syndrome during pregnancy, is very challenging. Herein we report a 35-year-old pregnant woman in her second trimester (16 weeks of gestational age) who presented with a productive cough and progressive dyspnea. She was diagnosed with a severe COVID-19 infection, confirmed by PCR testing. During hospitalization, she developed severe acute respiratory distress syndrome (ARDS) and was referred to a tertiary hospital. Despite the use of antiviral therapy, steroids, mechanical ventilators, and muscle relaxants, she still had significant hypoxemia. Thus, she underwent veno-venous extracorporeal membrane oxygenation (VV-ECMO). Due to the limitations of immunomodulatory therapy in pregnancy, our team decided to perform extracorporeal cytokine removal therapy with HA330 adsorbent hemoperfusion to remove circulatory cytokines and proinflammatory mediators and suppress the hyperinflammatory response. After 3 consecutive days of hemoperfusion, her C-reactive protein and interleukin-6 were controlled. On the 13th day of ICU admission, her clinical conditions, including pulmonary function, were improving, and she was successfully weaned off the VV-ECMO. A chest X-ray showed she was completely free of ARDs. The patient left the hospital with good clinical status and a viable fetus. We conclude that pregnant women infected with COVID-19 who develop refractory hypoxemia with cytokine storm syndrome may benefit from combined VV-ECMO and hemoperfusion as a rescue therapy.
Keywords
Full Text:
PDFReferences
CDC. Pregnant and recently pregnant people. [homepage on the Internet]. Georgia: Centers for Disease Control and Prevention; 2022 [cited 2022 Jun 4]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/pregnant-people.html
Zhou G, Chen S, Chen Z. Advances in COVID-19: the virus, the pathogenesis, and evidence-based control and therapeutic strategies. Front Med 2020;14:117-25. doi: 10.1007/s11684-020-0773-x.
Naoum EE, Chalupka A, Haft J, MacEachern M, Vandeven CJM, Easter SR, et al. Extracorporeal life support in pregnancy: a systematic review. J Am Heart Assoc 2020;9:e016072. doi: 10.1161/JAHA.119.016072.
Hou L, Li M, Guo K, Wang W, Li W, Li J, et al. First successful treatment of a COVID-19 pregnant woman with severe ARDS by combining early mechanical ventilation and ECMO. Heart Lung J Crit Care 2021;50:33-6. doi: 10.1016/j.hrtlng.2020.08.015.
Safari S, Salimi A, Zali A, Jahangirifard A, Bastanhagh E, Aminnejad R, et al. Extracorporeal hemoperfusion as a potential therapeutic option for severe COVID-19 patients; a narrative review. Arch Acad Emerg Med 2020;8:e67.
Kaçar CK, Uzundere O, Kandemir D, et al. Efficacy of HA330 hemoperfusion adsorbent in patients followed in the intensive care unit for septic shock and acute kidney injury and treated with continuous venovenous hemodiafiltration as renal replacement therapy. Blood Purif 2020;49:448-56. doi: 10.1159/000505565.
Kouhsari E, Azizian K, Sholeh M, Shayestehpour M, Hashemian M, Karamollahi S, et al. Clinical, epidemiological, laboratory, and radiological characteristics of novel Coronavirus (2019-nCoV) in retrospective studies: a systemic review and meta-analysis. Indian J Med Microbiol 2021;39:104-15. doi: 10.1016/j.ijmmb.2020.10.004.
Allotey J, Stallings E, Bonet M, Yap M, Chatterjee S, Kew T, et al. Clinical manifestations,Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ 2020;370:m3320. doi: 10.1136/bmj.m3320.
Rifkin BS, Stewart IJ. Seraph-100 hemoperfusion in SARS-CoV-2-infected patients early in critical illness: a case series. Blood Purif 2022;51:317-20. doi: 10.1159/000517430.
Abbasi S, Naderi Z, Amra B, Atapour A, Dadkhahi SA, Eslami MJ, et al. Hemoperfusion in patients with severe COVID-19 respiratory failure, lifesaving or not? J Res Med Sci Off J Isfahan Univ Med Sci 2021;26:34. doi: 10.4103/jrms.JRMS_1122_20.
Surasit K, Srisawat N. The efficacy of early additional hemoperfusion therapy for severe COVID-19 patients: a prospective cohort study. Blood Purif 2022;51:879-88. doi: 10.1159/000521713.
Mousavi-Roknabadi RS, Haddad F, Fazlzadeh A, Kheirabadi D, Dehghan H, Rezaeisadrabadi M, et al. Investigation of plasma exchange and hemoperfusion effects and complications for the treatment of patients with severe COVID-19 (SARS-CoV-2) disease: a systematic scoping review. J Med Virol 2021;93:5742-55. doi: 10.1002/jmv.27182.
Ballesteros DA, Santiago DR, Barrera ME, Mantilla AC. Hemoadsorption and continuous venovenous hemodiafiltration in the management of paraquat poisoning during pregnancy: a case report. Toxicol Rep 2023;11:449-51. doi: 10.1016/j.toxrep.2023.11.003.
Tang Y, Zhang L, Fu P, Kang Y, Liu F. Hemoperfusion plus continuous veno-venous hemofiltration in a pregnant woman with severe acute pancreatitis: a case report. Int Urol Nephrol 2012;44:987-90. doi: 10.1007/s11255-011-9936-7.
Karabulut Keklik ES, Dal H, Bozok Ş. Cytokine hemoadsorption in the management of a pregnant woman with COVID-19 pneumonia: case report. SN Compr Clin Med 2020;2:2376-2380. doi: 10.1007/s42399-020-00508-5.
Sharma NS, Wille KM, Bellot SC, Diaz-Guzman E. Modern use of extracorporeal life support in pregnancy and postpartum. ASAIO J Am Soc Artif Intern Organs 1992 2015;61:110-14. doi: 10.1097/MAT.0000000000000154.
Nair P, Davies AR, Beca J, et al. Extracorporeal membrane oxygenation for severe ARDS in pregnant and postpartum women during the 2009 H1N1 pandemic. Intensive Care Med 2011;37:648-54. doi: 10.1007/s00134-011-2138-z.
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.